Orgenesis
Cell & Gene Therapy
StartupOrgenesis is a Ness Ziona-based startup in the Health Tech & Life Sciences sector, established in 2008. Cell & Gene Therapy. The company has raised a total of $18.2M across 5 funding rounds, currently at the Public stage. Key investors include Kodiak Capital Group. The company has 11-50 employees. Core technologies: Biologicals, Cells.
With $18.2M in total funding, Orgenesis is a Public-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StagePublic
- ProductReleased
- ModelB2B
- Employees11-50
- HQNess Ziona
- DistrictCenter District
- Last RoundUndisclosed
- Kodiak Capital Group
85 articles covered by sources including www.biospace.com,
finance.yahoo.com,
www.biopharma-reporter.com,
www.proactiveinvestors.com,
www.globenewswire.com.
What does Orgenesis do?
Orgenesis is a pioneering global biotech company featuring a unique Cell & Gene Therapy Biotech Platform. The company is focused on unlocking the power of cell and gene therapies with this platform to provide life changing treatments at the Point of Care (POCare) to large numbers of patients at drastically reduced costs. The Platform consists of a pipeline of POCare Therapeutics; a suite of hand-selected and customized POCare Technologies for closed processing; and a collaborative, global POCare Network of leading companies, research institutes and hospitals. Working with this Platform, Orgenesis leverages cutting edge science to create a more efficient, scalable, and affordable pathway to patients. In June 2019, Orgenesis was granted an FDA orphan drug designation for its autologous insulin-producing cells.
How much funding has Orgenesis raised?
Orgenesis has raised $18.2M in total funding across 5 rounds. The company is currently at the Public stage. Key investors include Kodiak Capital Group.
What sector is Orgenesis in?
Orgenesis operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Cells. Target customers: Healthcare & Life Sciences, Healthcare, Laboratories, Providers, Life Sciences, Pharmaceuticals, Biotechnology.
Where is Orgenesis located?
Orgenesis is based in Pinhas Sapir St 8, Ness Ziona, Israel, Center District. The company also has offices abroad.